Redmile Group »

Ac Immune Sa shares owned by Redmile Group

Quarter-by-quarter ownership of Ac Immune Sa (ACIU) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Ac Immune Sa

Tip: Access up to 7 years of quarterly data

All positions including Ac Immune Sa held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ac Immune Sa by Redmile Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 2.0M 5.00

More positions owned by Redmile Group

ImmunoGen
Krystal Biotech (KRYS)
Amicus Therapeutics (FOLD)
Scholar Rock Hldg Corp (SRRK)
Rayzebio
Augmedix (AUGX)
Deciphera Pharmaceuticals (DCPH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Regenxbio Inc equity us cm (RGNX)
Biohaven (BHVN)
Zymeworks Del (ZYME)
Livanova SHS (LIVN)
Alx Oncology Hldgs (ALXO)
Catalent (CTLT)
Fate Therapeutics (FATE)

View all positions for Redmile Group

Top funds holding Ac Immune Sa

BVF
Avidity Partners Management
Redmile Group
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
Assenagon Asset Management
Handelsbanken Fonder AB
Dimensional Fund Advisors
Banque Cantonale Vaudoise
UBS Group
China Universal Asset Management
Goldman Sachs Group
Citadel Advisors
Royal Bank of Canada
Watch Point Trust

View all funds holding Ac Immune Sa